This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2009 Jun;5(6):302-3.

doi: 10.1038/nrendo.2009.100.

Diabetes: Which risk engines should be used to assess patients with diabetes?

Kausik K Ray, Naveed Sattar

PMID: 19465897
DOI: 10.1038/nrendo.2009.100

Diabetes: Which risk engines should be used to assess patients with diabetes?

Kausik K Ray et al. Nat Rev Endocrinol. 2009 Jun.

. 2009 Jun;5(6):302-3.

doi: 10.1038/nrendo.2009.100.

Authors

Kausik K Ray, Naveed Sattar

PMID: 19465897
DOI: 10.1038/nrendo.2009.100

No abstract available

PubMed Disclaimer

Comment in

Which risk engines are best to assess CVD risk in diabetes?
Chamnan P, Simmons RK, Griffin SJ. Chamnan P, et al. Nat Rev Endocrinol. 2010 Feb;6(2):2 p following 115. doi: 10.1038/nrendo.2009.100-c1. Nat Rev Endocrinol. 2010. PMID: 20104677 No abstract available.

Similar articles

Diabetes Mellitus and Its Cardiovascular Complications: New Insights into an Old Disease.
Sardu C, De Lucia C, Wallner M, Santulli G. Sardu C, et al. J Diabetes Res. 2019 May 19;2019:1905194. doi: 10.1155/2019/1905194. eCollection 2019. J Diabetes Res. 2019. PMID: 31236416 Free PMC article. No abstract available.
Young at heart. For people with type 2 diabetes, cardiovascular disease is enemy No. 1.
Curry A. Curry A. Diabetes Forecast. 2014 Dec;67(12):68-9. Diabetes Forecast. 2014. PMID: 25872369 No abstract available.
Effects of intensive blood pressure control in the management of patients with type 2 diabetes mellitus in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.
Mancia G. Mancia G. Circulation. 2010 Aug 24;122(8):847-9. doi: 10.1161/CIRCULATIONAHA.110.960120. Circulation. 2010. PMID: 20733113 No abstract available.
Cardiovascular risk assessment in type 2 diabetes mellitus.
Al-Ozairi E, Middelbeek RJ, Horton ES. Al-Ozairi E, et al. Curr Diab Rep. 2006 Nov;6(5):333-6. doi: 10.1007/s11892-006-0001-3. Curr Diab Rep. 2006. PMID: 17076992 Review. No abstract available.
The role of the thiazolidinediones in the practical management of patients with type 2 diabetes and cardiovascular risk factors.
Edelman SV. Edelman SV. Rev Cardiovasc Med. 2003;4 Suppl 6:S29-37. Rev Cardiovasc Med. 2003. PMID: 14668701 Review.

See all similar articles

Cited by

Does insulin resistance drive the association between hyperglycemia and cardiovascular risk?
Færch K, Bergman B, Perreault L. Færch K, et al. PLoS One. 2012;7(6):e39260. doi: 10.1371/journal.pone.0039260. Epub 2012 Jun 15. PLoS One. 2012. PMID: 22720085 Free PMC article.
Which risk engines are best to assess CVD risk in diabetes?
Chamnan P, Simmons RK, Griffin SJ. Chamnan P, et al. Nat Rev Endocrinol. 2010 Feb;6(2):2 p following 115. doi: 10.1038/nrendo.2009.100-c1. Nat Rev Endocrinol. 2010. PMID: 20104677 No abstract available.

References

1. Diabetologia. 2009 Mar;52(3):394-7 - PubMed
1. N Engl J Med. 2006 Dec 7;355(23):2427-43 - PubMed
1. Diabetes Care. 2009 Apr;32(4):708-13 - PubMed
1. N Engl J Med. 2004 Nov 4;351(19):1941-51 - PubMed
1. Circulation. 2007 Jan 2;115(1):114-26 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information